Tuesday, May 15, 2007

Day +69: Metaiodobenzylguanidine Anyone?

It’s back to Stanford tomorrow for some scheduled outpatient procedures. Keith will report to the nuclear medicine department and receive a radio-isotope injection for MIBG scans planned for Thursday and Friday. So this begins the first day of a solid week of tests for Keith extending all the way through next Wednesday intended to complete a full ‘work-up’ of his current condition. The results of these imaging tests will guide what next steps we will take and will determine in particular whether Keith is eligible to enroll in a promising but challenging phase III immunotherapy trial.

It will be a long week ahead but at least we get to sleep at home.

No comments: